© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Experts discuss recent data on next generation sequencing and germline testing in patients with advanced and metastatic cancer.
July 22nd 2021
Mark Robson, MD, and a panel of experts discuss key terminology and definitions related to tumor and germline sequencing.
Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.
July 29th 2021
A panel of experts share their experiences with interpreting information on somatic reports and provide recommendations for verifying results.
The panel of experts provide insight on how they identify patients for germline testing.
August 5th 2021
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss the evolving role of circulating tumor DNA (ctDNA) in germline testing.
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.